+ MUSE Alert

In this Issue

Table of Contents

  1. Open-Label PlaceboReflections on a Research Agenda
  2. Ted J. Kaptchuk
  3. pp. 311-334
  4. DOI: https://doi.org/10.1353/pbm.2018.0045
  5. restricted access
  1. Reining in the Placebo Effect
  2. Franklin G. Miller
  3. pp. 335-348
  4. DOI: https://doi.org/10.1353/pbm.2018.0046
  5. restricted access
  1. Editors' Introduction to Special Section on Meaning Response and the Placebo Effect
  2. Charlotte Blease, Marco Annoni, Phil Hutchinson
  3. pp. 349-352
  4. DOI: https://doi.org/10.1353/pbm.2018.0047
  5. restricted access
  1. Meaning and an Overview of the Placebo Effect
  2. Howard Brody
  3. pp. 353-360
  4. DOI: https://doi.org/10.1353/pbm.2018.0048
  5. restricted access
  1. The Meaning Response, "Placebo," and Methods
  2. Phil Hutchinson, Daniel E. Moerman
  3. pp. 361-378
  4. DOI: https://doi.org/10.1353/pbm.2018.0049
  5. restricted access
  1. A Critical (and Cautiously Optimistic) Appraisal of Moerman's "Meaning Response"
  2. Marco Annoni, Charlotte Blease
  3. pp. 379-387
  4. DOI: https://doi.org/10.1353/pbm.2018.0050
  5. restricted access
  1. The Placebo PhenomenonA Narrow Focus on Psychological Models
  2. Nathalie Peiris, Maxie Blasini, Thelma Wright, Luana Colloca
  3. pp. 388-400
  4. DOI: https://doi.org/10.1353/pbm.2018.0051
  5. restricted access
  1. What Are the Benefits of a New Placebo Language?
  2. Andrew Turner
  3. pp. 401-411
  4. DOI: https://doi.org/10.1353/pbm.2018.0052
  5. restricted access
  1. Consensus in Placebo StudiesLessons from The Philosophy of Science
  2. Charlotte Blease
  3. pp. 412-429
  4. DOI: https://doi.org/10.1353/pbm.2018.0053
  5. restricted access
  1. 200 Years After Frankenstein
  2. Christopher Nowlin
  3. pp. 430-449
  4. DOI: https://doi.org/10.1353/pbm.2018.0054
  5. restricted access
  1. Who's Winning the IRB Wars?The Struggle for the Soul of Human Research
  2. Nancy M. P. King
  3. pp. 450-464
  4. DOI: https://doi.org/10.1353/pbm.2018.0055
  5. restricted access